ARA 290 (cibinetide) is a synthetic 11–amino acid peptide derived from the non-erythropoietic region of erythropoietin, designed for research into tissue protection and nerve repair. It selectively targets the innate repair receptor pathway, allowing investigators to explore anti-inflammatory, cytoprotective, and small-fiber neuropathy–related mechanisms without stimulating red blood cell production. ARA 290 is being studied for its potential to modulate pro-inflammatory cytokines, support endothelial function, and improve nerve signaling in models of metabolic, renal, and neuropathic injury.